{
  "comments": [
    {
      "text": "In today's issue, JoongAng Ilbo reports on the February 8 evening briefing by the director of the Korean National Agency for Disease Control and Prevention, Jeong Eun-kyeong, at which the official officially announced for the first time that the South Korean authorities are considering the purchase and use of the Russian Sputnik V vaccine in the country.",
      "userName": "John Carter",
      "date": "Wed Feb 10 2021 09:07:47 GMT+0300 (Moscow Standard Time)",
      "id": 1
    },
    {
      "text": "It should be clarified that the Bureau of Pharmaceutical Products has not made any claims that AstraZeneca is not effective for people over 65 years of age. It is simply that we do not yet have sufficient information on this topic, and we should be very careful in this matter",
      "userName": "Chon Youn Pong",
      "date": "Wed Feb 10 2021 09:07:47 GMT+0300 (Moscow Standard Time)",
      "id": 2
    },
    {
      "text": "This decision is due to the disruption of Pfizer's program to use its vaccine in South Korea. The company violated the terms of delivery of the drug to South Korea. Pfizer is currently excluded from this program.",
      "userName": "Marta Caufman",
      "date": "Wed Feb 10 2021 09:16:11 GMT+0300 (Moscow Standard Time)",
      "id": 3
    },
    {
      "text": "lkjglkskdgdjg;ld;lgk;sdkg'kfd'gkkg'dkg;kds",
      "userName": "",
      "date": "Wed Feb 10 2021 14:14:33 GMT+0300 (Moscow Standard Time)",
      "id": 4
    },
    {
      "text": "fn.,f.mg,;s,g'f,b/,f./,/,f,g",
      "userName": "",
      "date": "Wed Feb 10 2021 14:14:43 GMT+0300 (Moscow Standard Time)",
      "id": 5
    }
  ]
}